logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
K

Kei Muro

department of clinical oncology

80H指数
1.0K论文数
4.4W被引数
收录论文 276
发表时间
logo
Phase II study of mFOLFOX6 in advanced gastric cancer patients with severe peritoneal metastases (WJOG10517G), including an individual patient data comparison with JCOG1108/WJOG7312G晚期胃癌伴严重腹膜转移患者mFOLFOX6方案的II期研究（WJOG10517G），包括与JCOG1108/WJOG7312G的个体患者数据比较
errGastric Cancer
IF5.1
err2026-08-27
err0
errOAAI
errToshiki Masuishi; Hiroki Hara; Takayuki Ando; Takeshi Kawakami; Yoshiyuki Yamamoto; Naotoshi Sugimoto; Kazuhiro Shiraishi; Taito Esaki; Yuji Negoro; Takao Tsuzuki; Hiroaki Sawai; Masato Nakamura; Takashi Inagaki; Yudai Shinohara; Kentaro Kawakami; Seiichiro Mitani; Kenji Tsuchihashi; Chihiro Kondoh; Hiroo Katsuya; Osamu Maeda; Yuriko Fujita; Kenichi Yoshimura; Masanori Terashima; Takako Eguchi Nakajima; Kei Muro
err分享
err收藏
Development of a visualization tool to estimate out-of-pocket costs for systemic cancer therapy in Japan and claims-based agreement evaluation: the VEST-Ca study开发用于估算日本系统性癌症治疗自付费用及基于理赔数据的协议评估的可视化工具：VEST-Ca研究
errJapanese Journal of Clinical Oncology
IF2.2
err2026-08-01
err0
PREAI
errHonda, Kazunori; Shimomura, Kazuhiro; Taniguchi, Hiroya; Kadowaki, Shigenori; Masuishi, Toshiki; Narita, Yukiya; Mizuno, Taro; Ando, Taiju; Ishizuka, Yasunobu; Umegaki, Sho; Ando, Masashi; Muro, Kei
err分享
err收藏
Study protocol of the C-SOLVE (JACCRO GC-12) trial; a randomized, non-comparative phase II trial of CapeOX or SOX plus zolbetuximab in HER2-negative, CLDN18.2-positive unresectable advanced gastric or esophagogastric junction cancerC-SOLVE (JACCRO GC-12)临床试验研究方案；一项关于CapeOX或SOX联合佐尔帕妥单抗治疗HER2阴性、CLDN18.2阳性不可切除的晚期胃或胃食管结合部癌的随机、非对照II期临床试验
errBMC Cancer
IF3.4
err2026-07-17
err0
errOAAI
errSatoshi Yuki; Hisato Kawakami; Kazuaki Harada; Yohei Kubota; Kyongsun Pak; Yoshihiro Kakeji; Masanori Terashima; Eishi Baba; Kei Muro; Yu Sunakawa; Wataru Ichikawa; Masashi Fujii
err分享
err收藏
Real-world evaluation of interstitial lung disease/pneumonitis in patients treated with trastuzumab deruxtecan for HER2-positive advanced or recurrent gastric cancer: a postmarketing surveillance study in Japan日本开展的真实世界评估：评估接受曲妥珠单抗德鲁替康治疗的HER2阳性晚期或复发性胃癌患者中发生的间质性肺疾病/肺炎：一项上市后监测研究
errESMO Open
IF8.3
err2025-12-04
err0
errOAAI
errH. Kawakami; K. Uchino; W. Hashimoto; K. Muro
err分享
err收藏
The FSTL1-DIP2A axis is a significant biomarker for predicting anti-PD1 therapeutic efficacy in advanced gastric cancerFSTL1-DIP2A轴是预测晚期胃癌抗PD1治疗效果的重要生物标志物。
errCancer Immunology, Immunotherapy
IF0
err2025-11-18
err0
errOAAI
errChie Kudo-Saito; Hiroshi Imazeki; Kengo Nagashima; Hirokazu Shoji; Kai Tsugaru; Naoki Takahashi; Takeshi Kawakami; Yusuke Amanuma; Takeru Wakatsuki; Fumio Nagashima; Yukiya Narita; Yoshiyuki Yamamoto; Rika Kizawa; Kei Muro; Narikazu Boku
err分享
err收藏
Systemic therapy strategies for elderly patients with gastric cancer老年胃癌患者的全身治疗策略
errTherapeutic Advances in Medical Oncology
IF4.2
err2025-08-16
err0
PREAI
errYukiya Narita; Kei Muro
err分享
err收藏
Ramucirumab-containing chemotherapy for patients with gastrointestinal neuroendocrine carcinoma refractory/intolerant to platinum-based chemotherapy: A multicenter observational retrospective study (WJOG13420G)含Ramucirumab的化疗方案用于对铂类为基础的化疗方案耐药/不耐受的胃肠道神经内分泌癌患者的疗效：一项多中心观察性回顾研究（WJOG13420G）
errInternational Journal of Cancer
IF4.7
err2025-07-23
err0
errOAAI
errYuki Matsubara; Toshiki Masuishi; Waki Hosoda; Hidekazu Hirano; Saori Mishima; Hiroyuki Takahashi; Tomoyuki Otsuka; Kenta Kawasaki; Takeshi Kawakami; Kazuhiro Yanagihara; Takaya Shimura; Masato Komoda; Kozue Murayama; Keiko Minashi; Yoshiyuki Yamamoto; Yudai Shinohara; Shinichi Nishina; Nobuyuki Musha; Kyoko Kato; Kentaro Kawakami; Katsunori Shinozaki; Kenji Tsuchihashi; Takayuki Ando; Yosuke Kito; Akitaka Makiyama; Seiichiro Mitani; Kaori Hino; Naoki Izawa; Isao Oze; Kei Muro
err分享
err收藏
Enfortumab vedotin in patients with advanced non-small cell lung cancer after disease progression on platinum- and PD-1/PD-L1 inhibitor-containing regimens: Phase 2 international multicenter EV-202 study恩沃利单抗（enfortumab vedotin）在铂类和PD-1/PD-L1抑制剂方案治疗后疾病进展的晚期非小细胞肺癌患者中的疗效：国际多中心EV-202期2研究
errEuropean Journal of Cancer
IF7.1
err2025-07-09
err0
errOAAI
errKei Muro; Trevor Feinstein; Joaquina Baranda; Ioana Bonta; Noriko Yanagitani; Todd Gersten; Leena Gandhi; Toshihiro Kudo; Naomi Fujioka; Jason Kaplan; Seema Gorla; Shubin Liu; Michele Wozniak; Srinivasu Poondru; Ryan Dillon; Changting Meng; Tejas Patil
err分享
err收藏
An observational study of the effectiveness and safety of nivolumab plus chemotherapy for untreated advanced or recurrent gastric cancer in Japanese real-world settings: the G-KNIGHT study一项关于纳武利尤单抗联合化疗在未经治疗的晚期或复发性胃癌日本真实世界中的有效性与安全性观察研究：G-KNIGHT研究
errGastric Cancer
IF5.1
err2025-07-09
err0
errOAAI
errShigenori Kadowaki; Tomoyuki Otsuka; Keiko Minashi; Shinichi Nishina; Hiroshi Yabusaki; Chiaki Inagaki; Tomohiro Nishina; Hisateru Yasui; Hiroshi Matsuoka; Nozomu Machida; Masahiro Tsuda; Fumio Nagashima; Hisashi Hosaka; Junichi Matsubara; Hiroyuki Arai; Satoshi Ida; Yuya Kimijima; Yuko Matsuda; Manabu Muto; Kei Muro
err分享
err收藏
Midline catheter use for cancer patients receiving 5-FU chemotherapy: prospective study of safety and outcomes中线导管在接收5-FU化疗的癌症患者中的应用：安全性与结局的前瞻性研究
errONCOLOGIST
IF4.2
err2025-05-27
err0
errOAAI
errSakakida, Tomoki; Fukahori, Shinichiro; Mizuno, Taro; Ishizuka, Yasunobu; Wakabayashi, Munehiro; Kodama, Hiroyuki; Narita, Yukiya; Masuishi, Toshiki; Honda, Kazunori; Kadowaki, Shigenori; Ando, Masashi; Muro, Kei; Ogawa, Akinobu; Kudo, Chiho; Oze, Isao
err分享
err收藏
Phase 1 study evaluating safety and pharmacokinetics of tusamitamab ravtansine monotherapy in Japanese patients with advanced malignant solid tumorsI期研究评估tusamitamab ravtansine单药治疗在日本晚期恶性实体瘤患者中的安全性和药代动力学。
errinternational journal of oncology
IF2.8
err2025-05-25
err0
errOAAI
errMuro, Kei; Yamazaki, Kentaro; Kadowaki, Shigenori; Mishima, Saori; Kawakami, Takeshi; Tanaka, Tomoyuki; Tada, Keisuke; Fagniez, Nathalie; Ohshima, Shinobu; Yoshino, Takayuki
err分享
err收藏
Optimal Primary Prophylaxis for Febrile Neutropenia During Neoadjuvant Cisplatin and 5-Fluorouracil Plus Docetaxel for Esophageal Cancer: A Retrospective Cohort Study奥沙利铂和5-氟尿嘧啶联合多西他赛新辅助治疗食管癌期间发热性中性粒细胞减少症的最佳一级预防：一项回顾性队列研究
errCANCER MEDICINE
IF3.1
err2025-04-24
err0
errOAAI
errKumanishi, Ryosuke; Taniguchi, Hiroya; Nakazawa, Taiko; Ogata, Takatsugu; Matsubara, Yuki; Kodama, Hiroyuki; Nakata, Akinobu; Honda, Kazunori; Masuishi, Toshiki; Narita, Yukiya; Kadowaki, Shigenori; Ando, Masashi; Tajika, Masahiro; Abe, Tetsuya; Muro, Kei
err分享
err收藏
First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors: 1-Year Follow-Up of the FIRST-Dx Study首次基因组分析在既往未治疗的晚期实体瘤中的应用：FIRST-Dx研究的1年随访
errCANCER SCIENCE
IF4.3
err2025-04-11
err0
errOAAI
errJunichi Matsubara; Kumi Mukai; Tomohiro Kondo; Masahiro Yoshioka; Hidenori Kage; Katsutoshi Oda; Sadakatsu Ikeda; Hiromichi Ebi; Kei Muro
err分享
err收藏
ASO Visual Abstract: Conversion from Radical Esophagectomy to Definitive Chemoradiotherapy after Neoadjuvant Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma: Treatment Options Based on Chemotherapy Response
errANNALS OF SURGICAL ONCOLOGY
IF3.5
err2025-03-01
err0
PREAI
errNarita, Kiyoshi; Higaki, Eiji; Abe, Tetsuya; Fujieda, Hironori; Hashimoto, Shingo; Kadowaki, Shigenori; Tajika, Masahiro; Kodaira, Takeshi; Muro, Kei; Shimizu, Yasuhiro
err分享
err收藏
Impact of ABCB1 single-nucleotide variants on early, extremely severe neutropenia induced by paclitaxel/nanoparticle albumin-bound paclitaxel in patients with gastric cancer
errBRITISH JOURNAL OF CLINICAL PHARMACOLOGY
IF3
err2024-12-02
err0
PREAI
errMaeda, Akimitsu; Matsuo, Keitaro; Ando, Hitoshi; Morishige, Jun-ichi; Muro, Kei; Uchida, Kosaku; Tajika, Masahiro
err分享
err收藏
Clinicopathological and prognostic significance of HER2-low expression in advanced gastric cancer: a retrospective observational studyHER2低表达在晚期胃癌中的临床病理及预后意义：一项回顾性观察性研究
errONCOLOGIST
IF4.2
err2024-12-01
err3
errOAAI
errNarita, Yukiya; Mizuno, Taro; Ishizuka, Yasunobu; Sakakida, Tomoki; Masuishi, Toshiki; Taniguchi, Hiroya; Kadowaki, Shigenori; Honda, Kazunori; Ando, Masashi; Tajika, Masahiro; Takahari, Daisuke; Muro, Kei
err分享
err收藏
Impacts of time-of-day of nivolumab infusion on treatment efficacy for patients with head and neck squamous cell carcinoma纳武利尤单抗输注时间对头颈鳞状细胞癌患者治疗疗效的影响
errANNALS OF ONCOLOGY
IF65.4
err2024-12-01
err0
PREAI
errTsunoki, T.; Kadowaki, S.; Mizuno, T.; Ishizuka, Y.; Sakakida, T.; Narita, Y.; Honda, K.; Masuishi, T.; Taniguchi, H.; Ando, M.; Muro, K.; Hanai, N.
err分享
err收藏
Myeloid subsets impede the efficacy of anti-PD1 therapy in patients with advanced gastric cancer (WJOG10417GTR study)
errJOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
err2024-11-03
err0
errOAAI
errShoji, Hirokazu; Kudo-Saito, Chie; Nagashima, Kengo; Imazeki, Hiroshi; Tsugaru, Kai; Takahashi, Naoki; Kawakami, Takeshi; Amanuma, Yusuke; Wakatsuki, Takeru; Okano, Naohiro; Narita, Yukiya; Yamamoto, Yoshiyuki; Kizawa, Rika; Muro, Kei; Aoki, Kazunori; Boku, Narikazu
err分享
err收藏
Safety and pharmacokinetics of tusamitamab ravtansine dosing Q3W in Japanese patients with advanced solid tumors
errANNALS OF ONCOLOGY
IF65.4
err2024-10-01
err0
PREAI
errMishima, S.; Muro, K.; Yamazaki, K.; Kadowaki, S.; Kuboki, Y.; Hamauchi, S.; Aoki, Y.; Ohshima, S.; Tada, K.; Fagniez, N.; Yoshino, T.
err分享
err收藏
A phase 1 study of zanidatamab monotherapy in Japanese patients with metastatic or unresectable HER2-expressing cancers
errANNALS OF ONCOLOGY
IF65.4
err2024-10-01
err0
PREAI
errDoi, T.; Muro, K.; Nishina, T.; Yamamoto, N.; Yang, L.; Grim, J.; Koyama, T.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
E
Eric Van Cutsem
H 指数: 174 · 论文数: 1.8K
D
David Cunningham
H 指数: 153 · 论文数: 2.1K
J
Jaffer A. Ajani
H 指数: 152 · 论文数: 1.7K
J
Josep M. Llovet
H 指数: 151 · 论文数: 794
J
Josep Tabernero
H 指数: 146 · 论文数: 2.7K
查看更多